PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, USA.\', \'Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA, USA.\', \'Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA, USA.\', \'University of Pittsburgh-Carnegie Mellon University Program in Computational Biology, Pittsburgh, PA, USA.\', \'Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.\', \'Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.\', \'National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.\', \'Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA, USA. yi.shi@pitt.edu pduprex@pitt.edu.\', \'Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, USA. yi.shi@pitt.edu pduprex@pitt.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • eabh031910.1126/sciadv.abh0319
?:doi
?:hasPublicationType
?:journal
  • Science advances
is ?:pmid of
?:pmid
?:pmid
  • 34039613
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.817
?:rankingScore_hIndex
  • 46
?:title
  • Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all